ITV

Tag: Sandeep Jain

  • Akums unveils BHAROSA campaign celebrating 20 years

    Akums unveils BHAROSA campaign celebrating 20 years

    Mumbai: Akums Drugs & Pharmaceuticals Ltd, a contract development and manufacturing organisations (CDMOs), launches its 20th anniversary campaign, “BHAROSA – Two Decades of Trust, Going Strong.” The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry. Through the Bharosa campaign, Akums seeks to raise awareness about its steadfast commitment to sustainability and innovation, both of which align with the company’s long-term vision and core values.

    In 2023, the Indian pharmaceutical market soared to a value of $22.7 billion. Projections indicate a robust trajectory, with expectations for the market to expand to $35.09 billion by 2028, showcasing a compound annual growth rate (CAGR) of 9.5 per cent during the period of 2023-2028. Akums’ success in the pharmaceutical industry is evident through its market leadership and commitment to innovation. With a market share of 9.3 per cent of the total addressable Indian domestic CDMO market by value and 8.8 per cent in the IPM market by volume in FY23, Akums has consistently demonstrated its leadership in the domestic CDMO market. Notably, its market share in the Indian domestic CDMO market surged to 29.4 per cent by value in FY23, up from 26.7 per cent in FY21.

    Akums Drugs & Pharmaceuticals Ltd MD Sanjeev Jain, expressed his sentiments on the occasion, stating, “April 19, 2004 marks a significant milestone for Akums as we celebrate two decades of longstanding and trusted relationships. Our dedication lies in continuously inspiring and fortifying this trust while cultivating collaborative relationships with all our stakeholders. We work diligently to adapt to customer demands. Our commitment extends beyond products. We strive to develop innovative formulations, while undertaking initiatives to contribute to the communities in which we have our operations.”. “

    Akums Drugs & Pharmaceuticals Ltd MD Sandeep Jain, echoed this sentiment, emphasising the company’s vision for the future, “Since its inception in 2004, Akums has established its commitment to innovation and excellence, manufacturing over 4,000 commercialised formulations across more than 60 dosage forms, across a range of therapeutic areas. With a focus on research and development, we developed over 200 formulations, addressing the evolving needs of our clientele. Akums is positioned to contribute to global healthcare solutions. Our 11 operating manufacturing units and four dedicated R&D facilities underscore our commitment to capacity and innovation. Supported by 24 in-house technologies and a team of 332 R&D scientists, we maintain an established track record of excellence in research and development. Looking ahead, our long-term vision for 2030 is to emerge as a global leader in pharmaceutical contract development and manufacturing, while steadfastly upholding our values of trust, excellence, and innovation.”

    As the ‘Dream Employer of the Year’ in 2023 (as awarded by Times Ascent), Akums prioritises workforce development to ensure product safety and consistency. With a global presence spanning 53 countries, the company is backed by major certifications such as WHO-GMP, ISO 9001:2015, and ISO 14001:2015, along with various international accreditations. Acknowledged for its commitment to excellence, Akums has received many awards and accolades, including the India Pharma Award for Excellence in Contract Research & Manufacturing for 2021 by Informa Markets.

    As Akums charts its course for continued growth and innovation, the Bharosa campaign highlights its position as a trusted and long-term resource to the pharmaceutical industry.

  • Vega aims to refresh cosmetic industry with SERY

    Vega aims to refresh cosmetic industry with SERY

    NEW DELHI: Personal care appliances brand Vega has forayed into the cosmetic brand with the name SERY. The company launched its product through e-commerce channels including its own website. SERY has entered the market with an easy-to-use, stick format make-up range.

    The brand has roped Bollywood actress Amyra Dastur as the brand ambassador. As part of the association, Dastur will be featured in the latest launch campaign video. 

    The company has expanded its footprints at a time when the cosmetic industry has been facing a steep decline due to the pandemic. Not only India but across the APAC region, many cosmetic brands have witnessed net sales decreased in the past few months.

    SERY MD Sandeep Jain shared, “The Covid2019 pandemic has had a negative impact on the industry. But many indigenous brands have started creating stronger e-commerce presence since offline has taken a hit. Individuals, particularly millennials, continue to purchase items via e-commerce platforms besides buying products directly from their favourite brands’ websites. So, having a strong presence in leading e-commerce platforms will be of help. However, retail will continue to be a point of focus for us in the near future.”

    VEGA has been a known brand in the personal care market. The company started its operation in 2006 as a makeup brush brand but transformed itself into a one-stop-shop brand for beauty care accessories and personal care appliances by 2013. 

    “Ever since we launched Vega in the Beauty Accessories and Personal Care Appliances category, our aim was to diversify into other segments. Although our initial plan was to bring everything together under one roof, we realised that launching a fresh brand would help in transforming the market without losing the intrinsic values of the respective brands,” he said.

    The idea behind launching a new brand, in an already cluttered market, was to bring the consumers something different and unique as a concept. “Being unique in terms of the pricing model and the product itself is of huge importance to brands today. The advent of the digital age has exposed the younger generation to a whole new world of products that are better, cheaper and more easily accessible,” he added.

    The brand mentioned that it’s not possible to have a retail presence right now, but a large population continues to shop from their favorite retail store instead of e-commerce.

    Jain also added that the pricing is competitive and comparable to big brands. Instead of the regular OOH billboard style of campaigns, the brand will look at digital for now.

  • Star Plus’ ‘Iss Pyaar Ko Kya Naam Doon’ travels to Namibia

    Star Plus’ ‘Iss Pyaar Ko Kya Naam Doon’ travels to Namibia

    MUMBAI: Viewers in Namibia will now have a reason to rejoice. Star India in partnership with content sales agency GoQuest Media Ventures has secured a deal with the Namibian Broadcasting Corporation for its popular series – ‘Iss Pyaar Ko Kya Naam Doon’.

     

    With this development, it makes ‘Iss Pyaar Ko Kya Naam Doon’ the first Indian TV series to reach the country.  The series is a light hearted love story of two individuals with opposite personalities entwined in a relationship swinging between love and hate, which captivated millions of viewers in India and abroad.

     

    Commenting on the success of the show across geographies, Star India head – commercial and procurement Sandeep Jain said, “Is Pyaar Ko Kya Naam Doon has been licensed to ten territories in very a short span of time, and we’re humbled with the response that the show has received. We have had a productive and long-standing association with GoQuest Media, and with their support, we have also been able to license this highly popular series to territories like Nigeria and Uganda in Africa.”

     

    GoQuest MD Vivek Lath believes that there is a tremendous demand for Indian content in Africa as broadcasters in many African countries rely on Indian films and TV series to meet the audiences’ ever-increasing demands.

     

    The choice of the show comes after a careful selection done by the channel in order to show the Namibian viewers a love story that’s one of the most loved and appealing TV series from India. The series was aired in India on Star Plus.

     

    As a content sales agency with strong relationships in Africa, MENA, Eastern Europe, the Caribbean and South-East Asia, GoQuest Media contends to reach newer territories this year with the best of Indian content.

  • Balaji Telefilms Q4 net at Rs 155 million

    Balaji Telefilms Q4 net at Rs 155 million

    MUMBAI: Balaji Telefilms has posted a net profit of Rs 155.03 million for the quarter ended 31 March 2006 as compared to Rs 96.47 million a year ago.

    The total income has increased to Rs 781.40 million, up from Rs 568.44 million during this period.

    For the entire fiscal, the company has posted a net profit of Rs 596.428 million as against Rs 412.962 million for the year ended 31 March 2005.

    Total income for the year was Rs 2.9 billion, up from Rs 2.01 billion a year ago.

    The board of directors has recommended a full and final dividend of Rs 3 per share (150 per cent on par value of Rs 2 per share), subject to the approval of members at the ensuing annual general meeting.

    Balaji Telefilms chief financial officer V Devarajan has put in his papers, the company said. Sandeep Jain will take over as the CFO of the company.